Baxter International Inc. (BAX)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Infusion Therapies & Platforms Revenue	5.44B	4.10B	4.10B
Advanced Surgery Revenue	1.27B	1.20B	1.10B
Medical Products & Therapies Revenue	6.71B	5.30B	5.21B
Care & Connectivity Solutions Revenue	1.95B	1.91B	1.81B
Front Line Care Revenue	1.16B	1.16B	1.14B
Healthcare Systems & Technologies Revenue	3.11B	3.07B	2.95B
Injectables and Anesthesia Revenue	-	1.35B	1.37B
Drug Compounding Revenue	-	1.14B	1.04B
Pharmaceuticals Revenue	-	2.49B	2.41B
Other Revenue (Post-Q2 2023 Reporting)	351.00M	381.00M	67.00M
Revenue (Other)	-8.52B	-10.86B	-10.57B
Revenue (Total)	11.47B	11.24B	10.64B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	6.13B	6.12B	5.85B
Emerging Markets Revenue	-	1.39B	1.35B
Rest of World Revenue	-	3.73B	3.44B
International Revenue	5.34B	5.12B	4.79B
Revenue (Other)	-	-5.12B	-4.79B
Revenue (Total)	11.47B	11.24B	10.64B

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Medical Products & Therapies Operating Income	1.24B	970.00M	950.00M
Healthcare Systems & Technologies Operating Income	492.00M	441.00M	468.00M
Pharmaceuticals Operating Income	-	222.00M	313.00M
Other Operating Income	41.00M	43.00M	18.00M
Operating Income (Total)	-274.00M	-308.00M	14.00M

Data Source: Fiscal.ai Last updated: Jul 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error